An epigenome-wide association study of inflammatory response to fenofibrate in the Genetics of Lipid Lowering Drugs and Diet Network

AIM: Fenofibrate, a PPAR-α inhibitor used for treating dyslipidemia, has well-documented anti-inflammatory effects that vary between individuals. While DNA sequence variation explains some of the observed variability in response, epigenetic patterns present another promising avenue of inquiry due to...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Pharmacogenomics
Prif Awduron: Yusuf, Nabiha, Hidalgo, Bertha, Irvin, Marguerite R, Sha, Jin, Zhi, Degui, Tiwari, Hemant K, Absher, Devin, Arnett, Donna K, Aslibekyan, Stella W
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Future Medicine Ltd 2017
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5593083/
https://ncbi.nlm.nih.gov/pubmed/28835163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs-2017-0037
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg